Naloxone - NDC Database
120 records found
Page:
0093-2165 Dec 22, 2021
Naloxone Hydrochloride 4 mg/.1ml Nasal Spray, Metered by Teva Pharmaceuticals USA, Inc.
Naloxone Hydrochloride 4 mg/.1ml Nasal Spray, Metered by Teva Pharmaceuticals USA, Inc.
0404-9920 Jan 13, 2022
Naloxone Hydrochloride .4 mg/ml Intramuscular; Intravenous; Subcutaneous Injection, Solution by Henry Schein, Inc.
Naloxone Hydrochloride .4 mg/ml Intramuscular; Intravenous; Subcutaneous Injection, Solution by Henry Schein, Inc.
0404-9923 Jan 13, 2022
Naloxone Hydrochloride .4 mg/ml Intramuscular; Intravenous; Subcutaneous Injection, Solution by Henry Schein, Inc.
Naloxone Hydrochloride .4 mg/ml Intramuscular; Intravenous; Subcutaneous Injection, Solution by Henry Schein, Inc.
0409-1212 Jan 07, 1987
Naloxone Hydrochloride .4 mg/ml Intramuscular; Intravenous; Subcutaneous Injection, Solution by Hospira, Inc.
Naloxone Hydrochloride .4 mg/ml Intramuscular; Intravenous; Subcutaneous Injection, Solution by Hospira, Inc.
0409-1215 May 01, 2014
Naloxone Hydrochloride .4 mg/ml Intramuscular; Intravenous; Subcutaneous Injection, Solution by Hospira, Inc.
Naloxone Hydrochloride .4 mg/ml Intramuscular; Intravenous; Subcutaneous Injection, Solution by Hospira, Inc.
0409-1219 Apr 09, 2014
Naloxone Hydrochloride .4 mg/ml Intramuscular; Intravenous; Subcutaneous Injection, Solution by Hospira, Inc.
Naloxone Hydrochloride .4 mg/ml Intramuscular; Intravenous; Subcutaneous Injection, Solution by Hospira, Inc.
0409-1782 Sep 23, 2005
Naloxone Hydrochloride .4 mg/ml Intramuscular; Intravenous; Subcutaneous Injection, Solution by Hospira, Inc.
Naloxone Hydrochloride .4 mg/ml Intramuscular; Intravenous; Subcutaneous Injection, Solution by Hospira, Inc.
0480-3478 Sep 23, 2024
Naloxone Hydrochloride 4 mg/.1ml Nasal Spray, Metered by Teva Pharmaceuticals, Inc.
Naloxone Hydrochloride 4 mg/.1ml Nasal Spray, Metered by Teva Pharmaceuticals, Inc.
0548-1469 Apr 01, 1988
Naloxone Hydrochloride 1 mg/ml Parenteral Injection by Amphastar Pharmaceuticals, Inc.
Naloxone Hydrochloride 1 mg/ml Parenteral Injection by Amphastar Pharmaceuticals, Inc.
0548-3369 Jun 01, 2001
Naloxone Hydrochloride 1 mg/ml Parenteral Injection by Amphastar Pharmaceuticals, Inc.
Naloxone Hydrochloride 1 mg/ml Parenteral Injection by Amphastar Pharmaceuticals, Inc.
0591-2971 Jan 20, 2023
Naloxone Hydrochloride 4 mg/.1ml Nasal Spray, Metered by Actavis Pharma, Inc.
Naloxone Hydrochloride 4 mg/.1ml Nasal Spray, Metered by Actavis Pharma, Inc.
0641-6132 Sep 24, 1986
Naloxone Hydrochloride .4 mg/ml Intramuscular; Intravenous; Subcutaneous Injection by West-ward Pharmaceuticals Corp.
Naloxone Hydrochloride .4 mg/ml Intramuscular; Intravenous; Subcutaneous Injection by West-ward Pharmaceuticals Corp.
0641-6205 Jun 10, 2022
Naloxone Hydrochloride 1 mg/ml Intramuscular; Intravenous; Subcutaneous Injection by Hikma Pharmaceuticals USA Inc.
Naloxone Hydrochloride 1 mg/ml Intramuscular; Intravenous; Subcutaneous Injection by Hikma Pharmaceuticals USA Inc.
0641-6260 Mar 01, 2022
Naloxone Hydrochloride .4 mg/ml Intramuscular; Intravenous; Subcutaneous Injection by Hikma Pharmaceuticals USA Inc.
Naloxone Hydrochloride .4 mg/ml Intramuscular; Intravenous; Subcutaneous Injection by Hikma Pharmaceuticals USA Inc.
17478-041 Feb 28, 2017
Naloxone Hydrochloride .4 mg/ml Intramuscular; Intravenous; Subcutaneous Injection, Solution by Akorn, Inc.
Naloxone Hydrochloride .4 mg/ml Intramuscular; Intravenous; Subcutaneous Injection, Solution by Akorn, Inc.
17478-042 Mar 14, 2017
Naloxone Hydrochloride .4 mg/ml Intramuscular; Intravenous; Subcutaneous Injection, Solution by Akorn, Inc.
Naloxone Hydrochloride .4 mg/ml Intramuscular; Intravenous; Subcutaneous Injection, Solution by Akorn, Inc.
Page:
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.